ViralGuard
ViralGuard focuses on developing broad-spectrum antiviral therapies and vaccines for infectious diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $300M
About
ViralGuard focuses on developing broad-spectrum antiviral therapies and vaccines for infectious diseases.
Infectious DiseaseVaccines
Funding History
1Total raised:$300M
Series A$300M